Skip to main content

Find Clinical Trials

Home
Conditions
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

Clinical trial condition

High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

Explore clinical trials studying High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma trial results

Recruiting

Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)

NCT05962541

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations: AOU Policlinico Umberto I Hospital, UOC Urologia SMUC05, Rome, Italy Rome, Lazio, Italy

View Trial Details

Active, Not Recruiting

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

NCT05843448

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, +12 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details